RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in the domestic and international market.
The company is a part of RPG group which is a diversified conglomerate with interests in areas of infrastructure, tyres, information technology, pharmaceuticals, energy and plantations. The group is headed by Harsh Goenka.
Financial Results:
RPG Life Sciences Ltd reported Revenues for Q2FY24 of ₹154.00 Crores up from ₹135.00 Crore year on year, a rise of 14.07%.
Total Expenses for Q2FY24 of ₹120.00 Crores up from ₹109.00 Crores year on year, a rise of 10.09%.
Consolidated Net Profit of ₹26.00 Crores up 30.0% from ₹20.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹15.64, up 29.58% from ₹12.07 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.